SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-081564
Filing Date
2021-06-15
Accepted
2021-06-15 17:11:49
Documents
2
Period of Report
2021-06-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119755d1_8k.htm 8-K 29121
2 EXHIBIT 3.1 tm2119755d1_ex3-1.htm EX-3.1 8447
  Complete submission text file 0001104659-21-081564.txt   39228
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 211019525
SIC: 3845 Electromedical & Electrotherapeutic Apparatus